Raymond James Financial’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Raymond James Financial's AMGN Position: Q1 2026 in Review
Raymond James Financial reduced its Amgen (AMGN) stake by 4.8% in Q1 2026, selling an estimated $29.4M and leaving 1,620,353 shares worth $570M. The position accounts for 0.18% of the portfolio, ranked #99.
Raymond James Financial first reported a position in AMGN in Q4 2024 and has held it in 6 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Raymond James Financial held 1,620,353 shares of Amgen worth $570M as of Q1 2026.
- Raymond James Financial sold 82,397 Amgen shares in Q1 2026, an estimated $29.4M.
- Amgen made up 0.18% of Raymond James Financial's portfolio in Q1 2026, its #99 holding.
- Raymond James Financial first reported a position in Amgen in Q4 2024 and has held it in 6 quarters since.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.